Literature DB >> 12743645

Combining medical informatics and bioinformatics toward tools for personalized medicine.

B D Sarachan1, M K Simmons, P Subramanian, J M Temkin.   

Abstract

OBJECTIVES: Key bioinformatics and medical informatics research areas need to be identified to advance knowledge and understanding of disease risk factors and molecular disease pathology in the 21 st century toward new diagnoses, prognoses, and treatments.
METHODS: Three high-impact informatics areas are identified: predictive medicine (to identify significant correlations within clinical data using statistical and artificial intelligence methods), along with pathway informatics and cellular simulations (that combine biological knowledge with advanced informatics to elucidate molecular disease pathology).
RESULTS: Initial predictive models have been developed for a pilot study in Huntington's disease. An initial bioinformatics platform has been developed for the reconstruction and analysis of pathways, and work has begun on pathway simulation.
CONCLUSIONS: A bioinformatics research program has been established at GE Global Research Center as an important technology toward next generation medical diagnostics. We anticipate that 21 st century medical research will be a combination of informatics tools with traditional biology wet lab research, and that this will translate to increased use of informatics techniques in the clinic.

Entities:  

Mesh:

Year:  2003        PMID: 12743645

Source DB:  PubMed          Journal:  Methods Inf Med        ISSN: 0026-1270            Impact factor:   2.176


  2 in total

1.  Modeling complex workflow in molecular diagnostics: design specifications of laboratory software for support of personalized medicine.

Authors:  Mohamed E Gomah; James P Turley; Huimin Lu; Dan Jones
Journal:  J Mol Diagn       Date:  2009-12-10       Impact factor: 5.568

2.  A computational positron emission tomography simulation model for imaging beta-amyloid in mice.

Authors:  Melvin K Simmons; Ravindra Manjeshwar; Eric D Agdeppa; Robert M Mattheyses; Thomas R Kiehl; Michael C Montalto
Journal:  Mol Imaging Biol       Date:  2005 Jan-Feb       Impact factor: 3.488

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.